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Abstract We performed an extended oral glucose toler-
ance test (OGTT) to investigate the relationship between
early and late beta-cell response and type 2 diabetes (T2D)
in families of South Asian origin and indigenous Dutch,
burdened by T2D. Based on the OGTT, 22 individuals
were normoglycemic, 12 glucose intolerant and 23 had
T2D in the South Asian families; these numbers were 34,
12 and 18 in the Caucasian families, respectively. The
OGTT had 11 blood samplings in 3.5 h for glucose, insulin
and C-peptide measurements. Through early and late
insulin secretion rate (ISR), the above basal glucose area-
under-the-curve after glucose load (glucose disposal) and
insulin sensitivity index (ISI), we obtained early and late
disposition indices (DI). South Asians on average had
lower ISI than Caucasians (3.8 ± 2.9 vs. 6.5 ± 4.7,
respectively, P \ 0.001), with rapid decline of their early
and late DI between normal glucose tolerance versus
impaired fasting glucose/impaired glucose tolerance (late
DI; P \ 0.0001). Adjusted for ISI, age, gender and waist-
to-hip ratio, early ISR was significantly associated with
glucose disposal in South Asians (b = 0.55[0.186; 0.920]),
but not in Caucasians (b = 0.09[-0.257; 0.441]). Simi-
larly, early ISR was strongly associated with late ISR
(b = 0.71[0.291; 1.123]; R2 = 45.5 %) in South Asians,
but not in Caucasians (b = 0.27[-0.035; 0.576];
R2 = 17.4 %), with significant interaction between eth-
nicity and early ISR (b = 0.341[0.018; 0.664]). Ordinal
regression analyses confirmed that all South Asian OGTT
subgroups were homogenously resistant to insulin and
solely predicted by early ISR (b = -0.782[-1.922;
0.359], b = -0.020[-0.037; -0.002], respectively), while
in Caucasian families both ISI and early ISR were related
to glucose tolerance state (b = -0.603[-1.105; -0.101],
b = -0.066[-0.105; -0.027], respectively). In South
Asian individuals, rapid beta-cell deterioration might occur
under insulin resistant conditions. As their early insulin
response correlates strongly with both glucose disposal and
late insulin response, alterations in beta-cell dynamics may
give an explanation to their extreme early onset of T2D,
although larger prospective studies are required.
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Introduction
Dutch citizens of South Asian origin have a nearly fivefold
higher prevalence of type 2 diabetes (T2D) than the
indigenous Dutch population (further described as Cauca-
sian) [1, 2]. The increased susceptibility to T2D is also
evident from the early onset of the disorder at relatively
low body mass and the remarkably high incidence of car-
diovascular and microvascular damage among the South
Asians [2, 3]. A number of factors have been proposed to
account for this strikingly high risk in South Asians,
including a high prevalence of metabolic syndrome,
impaired maternal lipid profile conditions, low birth weight
causing central obesity later in life, dysfunction of adipo-
cytes, as well as educational, social and economic
inequalities [4–14]. These factors all enhance insulin
resistance and promote hyperinsulinemia [14, 15]. In
addition, T2D is characterized by beta-cell dysfunction.
Genetic loci predisposing individuals to T2D affect both
beta-cell function and insulin action [16, 17].
The ancestors of South Asian families in the Nether-
lands moved from a circumscribed region in India to Su-
rinam. During the past 150 years, these South Asian
families lived largely in genetic isolation before arriving in
the Netherlands. The conservation of susceptibility loci
may have contributed to the strong aggregation of T2D in
these families. We hypothesized that, in addition to severe
resistance to insulin, these South Asian families are also
predisposed to develop beta-cell dysfunction. Therefore,
we investigated beta-cell function and insulin sensitivity
simultaneously in South Asian and Caucasian patients with
T2D and first-degree relatives. In effect, we assessed the
contribution to the risk of T2D of changes in early and late
insulin secretion rates (ISR) and insulin sensitivity during
an extended oral glucose tolerance test (OGTT) with
insulin and C-peptide measurements.
Methods
Subjects
The study was conducted during a time period between
August 2007 and January 2011. Patients with T2D and
first-degree relatives without T2D were recruited from 36
South Asian families and 24 Caucasian families
(Scheme 1). Power calculation was performed with Quanto
version 1.0 [31] and was based on differences in early
phase ISR (described further on in Methods section)
between healthy South Asian and Caucasian performed in a
pilot phase of the study among, with alpha 0.05 and power
80 %. All probands were attending the outpatient clinic of
the Department of Internal Medicine of the Erasmus
Medical Center in Rotterdam. T2D was diagnosed
according to World Health Organization (WHO) criteria
[18]: plasma glucose level C7.0 mmol/L in a fasting state
and/or C11.1 mmol/L in a non-fasting state. Inclusion
criteria for probands were age of 18 years or older and T2D
in at least one sibling. Both parents of the South Asian
probands were of South Asian origin, and Caucasian pro-
bands were born in the Netherlands with both parents of
Caucasian Dutch origin. Exclusion criteria were insulin-
dependent diabetes mellitus, using medication other than
metformin, a history of pancreatitis, insulinoma or other
reasons that made participation impossible. Written
informed consent was obtained from all participants. The
study protocol was approved by the Erasmus Medical
Center Medical Ethics Review Board.
Physical examination
Body height and weight were measured to the nearest
0.1 cm and 0.1 kg for the determination of body mass
index (BMI). Waist circumference was measured in cm
halfway between the lowest rib and the iliac crest, the
maximum circumference of the hips was measured in the
standing position in cm, and, from these measurements,
the waist-to-hip ratio (W/H) was calculated. Systolic and
diastolic blood pressures were measured with an electronic
blood pressure monitor (Datascope Accutorr Plus Inc.,
Montvale, NJ) after five minutes rest in the sitting
position.
Oral glucose tolerance test (OGTT)
Glucose, 75 g dissolved in 200 ml H2O, was administered
orally after a 10-h overnight fast. Venous blood was drawn
via an intravenous canula, 60 and 15 min before the glu-
cose load and 15, 30, 45, 60, 90, 120, 150, 180 and 210 min
after glucose loading. WHO criteria based on OGTT were
used to define family members with normal glucose tol-
erance (NGT), impaired fasting glucose/impaired glucose
tolerance (IFG/IGT) and T2D [18].
Assays
Plasma glucose was measured by a hexokinase-based
method (Gluco-quant; Roche Diagnostics, Mannheim,
Germany). Plasma insulin and C-peptide were measured
separately by a competitive chemiluminescent immunoas-
say, supplied by Euro/DPC (Diagnostic Product Corpora-
tion, Los Angeles, CA). The assay was performed on a
DPC Immulite 2000 analyzer (Euro/DPC) according to the
manufacturer’s recommended protocol.
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Calculation of indices
Beta-cell function indices
For the assessment of early, late and overall beta-cell
function, we calculated incremental ISR area-under-the
curves (AUCs); ISR t0–30 and ISR t60–210 and ISR
t0–210, respectively, based on plasma C-peptide concen-
trations with ISEC software [19]. The ISR reflects the
prehepatic secretion rate, as C-peptide has negligible
hepatic clearance. Hereafter, we investigated early, late and
overall beta-cell function in relation to glucose concen-
trations and insulin sensitivity to obtain early, late, and
overall disposition indices (DI), respectively.
Insulin sensitivity
The insulin sensitivity index (ISI) was determined
according to [20, 21]
ISI ¼ 10:000=ðG0  I0  meanG0306090120
 meanI0306090120Þ1=2:
Early, late and overall Disposition Indices
Early, late and overall DI were calculated as follows: ISR
t0–30/glucose disposal t0–30 9 ISI, ISR t60–210/glucose
disposal t60–210 9 ISI and ISR t0–210/glucose disposal
t0–210 9 ISI, respectively [22]. In addition, we calculated
the ratio of late phase DI to early phase DI, based on earlier
observations marking their relationship [23].
To improve comparison with previous studies, we also
added a large number of classical indices to online sup-
plemental Table 1 and supplemental Figure 1. All for-
mulae are described below the online supplemental
Table 1. All OGTT indices were derived from insulin and
C-peptide concentrations in pmol/L and glucose concen-
trations in mmol/L, with the exception that insulin con-
centrations were converted to lU/mL for the calculation
of HOMA and ISI and, subsequently, DIs were both
calculated with glucose in mg/dL. All AUCs were cal-
culated according to the trapezoid method, and incre-
mental AUCs were calculated by subtracting basal values
from total calculated AUC values between given time
points [24].
Scheme 1 Inclusion flow chart of individuals from South Asian and Caucasian families
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Statistical analyses
We performed family-based analyses with the SOLAR
software package [25]. Comparison between ethnicities
was performed with variance component analyses adjusted
for a number of covariates within SOLAR. For the pre-
diction of NGT, IFG/IGT or T2D stage (WHO OGTT
subgroup) in both ethnicities, we used ordinal regression
analyses with SPSS version 15.0 for Windows (SPSS Inc.,
Chicago, IL, USA), adjusted for family ties, using a vari-
able grouping each family with their own distinct number
in SPSS. Data are expressed as mean ± SD, unless other-
wise indicated. ANOVA were used for differences within
given WHO OGTT subgroups and performed with SPSS;
for each WHO OGTT subgroup, three comparisons were
performed with ANOVA (unless otherwise stated); with
the other two WHO OGTT subgroups of same ethnicity
and with the corresponding other ethnic WHO OGTT
subgroup. Inverse or log transformations were used when
normality, or equal variance assumptions were not met.
P value \0.05 was considered significant, unless otherwise
stated.
Results
In 36 South Asian families, 15 out of 37 (41 %) apparently
healthy first-degree relatives were classified as IFG
(n = 4), IGT (n = 5), the combination of IFG and IGT
(n = 3) or newly diagnosed T2D (n = 3). In 24 Caucasian
families, 13 (28 %) out of 47 apparently healthy first-
degree relatives were classified as IFG (n = 3), IGT
Table 1 Clinical characteristics of the NGT, IGT and/or IFG and T2D subgroups
NGT SA NGT Cau IFG/IGT SA IFG/IGT Cau T2D SA T2D Cau
n 22 34 12 12 23 18
Sex(male/female), n %(male) 10/12 (45.5) 11/23 (32.4) 8/4 (66.7) 4/8 (33.3) 11/12 (47.8) 9/9 (50.0)
Age (years) 39.6 ± 11.6} 38.9 ± 9.4 46.3 ± 8.8 44.5 ± 11.4 52.3 ± 8.8§ 63.2 ± 7.6*}
Weight (kg) 78.7 ± 13.8 81.1 ± 15.7 78.7 ± 14.5 94.1 ± 30.4 74.4 ± 12.4 90.5 ± 15.0}
Length (cm) 1.69 ± 0.1 1.75 ± 0.1 1.67 ± 0.1 1.75 ± 0.1 1.61 ± 0.1 1.76 ± 0.1}
BMI (kg/m2) 27.6 ± 4.1 26.3 ± 4.1 27.9 ± 2.9 30.4 ± 8.5 28.6 ± 4.1 29.3 ± 4.9
Waist (cm) 94 ± 10 91 ± 15 98 ± 13 105 ± 20 97 ± 11 105 ± 14*
Hip (cm) 105 ± 5 108 ± 8 103 ± 6 116 ± 20 104 ± 9 112 ± 10
W/H 0.90 ± 0.07 0.84 ± 0.09 0.95 ± 0.10 0.90 ± 0.07 0.93 ± 0.08 0.94 ± 0.08*
RR systolic (mmHg) 122.6 ± 14.1 123.2 ± 12.5 125.9 ± 15.0 129.6 ± 20.2 132.4 ± 15.1 135.6 ± 13.0
RR diastolic (mmHg) 77.0 ± 9.7 76.3 ± 9.1 85.0 ± 10.8 79.4 ± 10.3 80.4 ± 8.4 83.4 ± 12.2
Smoking, n %D 2 (11.8) 13 (40.6) (5) 55.6 (5) 50.0 8 (50.0) 5 (50.0)
Antihypertensive, n % 2 (9.1) 0 2 (16.7) 3 (25.0) 9 (39.1) 9 (50.0)*
Lipid treatment, n % 3 (13.6) 1 (2.9) 3 (25.0) 0 11 (47.8) 11 (61.1)*
Macrovascular history, n % 4.5 3.0 16.7 0 8.7 12.5*
Microvascular history, n % 13.0B 25.0B
Metformin usage 20(87 %) 17(94.4 %)
Age of diagnosis 44.3 ± 7.3A,B 56.1 ± 7.2A,B
Period of having T2D 9.9 ± 7.3A,C 8.5 ± 8.4A,C
Fasting glucose (mmol/L) 5.3 ± 0.4} 5.2 ± 0.3 6.0 ± 0.5} 6.0 ± 0.6* 7.2 ± 1.1§|| 8.0 ± 1.1*
120 min glucose (mmol/L) 5.4 ± 1.1} 5.5 ± 1.1 7.8 ± 1.1} 7.7 ± 2.3* 12.5 ± 4.4§|| 14.1 ± 3.6*
ISI 5.0 ± 3.9 8.2 ± 5.1 3.2 ± 1.8 5.0 ± 3.2 2.9 ± 1.6 4.2 ± 3.3*
ISR t0–210 1,647 ± 852 1,153 ± 385 1,873 ± 862 1,369 ± 561 1,645 ± 513 1,060 ± 478
ISR t0–30 297 ± 122*} 208 ± 82 254 ± 158} 166 ± 69 116 ± 64§|| 124 ± 75
ISR t60–210 921 ± 632 595 ± 296 1,217 ± 699 900 ± 524 1,225 ± 430 744 ± 360
Glucose disposal t0–210 169 ± 95} 211 ± 126 394 ± 138} 446 ± 176 830 ± 438§|| 1,035 ± 445*
Glucose disposal t0–30 33 ± 17 35 ± 14 40 ± 14 44 ± 27 51 ± 22§ 70 ± 23*
Glucose disposal t60–210 73 ± 60} 99 ± 81 239 ± 107} 281 ± 162 611 ± 383§|| 764 ± 405*
Data are mean ± SD, n or n(%). P values are from ANOVA, P values between subgroups in post hoc Bonferroni analysis denoting statistical
significance (P \ 0.0125) are shown with symbols; * versus Cau NGT, versus Cau IFG/IGT, versus Cau T2D, §versus SA NGT, ||versus SA
IFG/IGT, }versus SA T2D. Anewly identified individuals with T2D excluded, Bsignificance, Cnon-significance with Student’s t test or v2 test
P \ 0.05, Dincomplete data, however, with a [75 % response rate
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(n = 5), the combination of IFG and IGT (n = 4), while
one was newly identified as T2D. For both ethnic groups,
individuals with IFG and/or IGT were combined into one
group of intermediate phenotypes and newly identified
individuals with T2D were included with the original T2D
cases in the diabetes group. The general characteristics of
the three groups according to ethnicity are shown in
Table 1. Waist circumference and W/H were lower in the
groups with NGT compared with the other groups in both
ethnicities. However, the relation of increasing W/H with
glucose intolerance appeared to be less clear in South
Asians when compared to Caucasians Notably, the South
Asians with T2D were on average 10 years younger than
the Caucasians with T2D and they already had a substantial
prevalence of macrovascular disorders. Results from the
OGTT demonstrated the following results; in both ethnic-
ities with increasing glucose intolerance, glucose disposal
increased, while both ISR t0–30 min and ISI decreased.
Both ISR t0–210 min and ISR t60–210 min increased from
NGT toward IFG/IGT, but decreased from IFG/IGT toward
T2D. In general, ISR derived parameters in South Asians
were markedly higher compared with the Caucasians,
while ISI was lower with an overall between ethnicity
difference of 3.8 ± 2.9 versus 6.5 ± 4.7, respectively
(P \ 0.001).
Disposition indices, first/second phase beta-cell
function
The unadjusted relationships between glucose disposal
t0–210 min, ISR t0–30 min and ISR t60–210 min are
shown in ternary plots (Supplementary Figure 1a, c). We
determined the relationship between ISR t0–30 and ISR
t60–210 with glucose disposal t0–210 using variance
component analyses; after adjustment for ISI, age, W/H
and gender the effect of early beta-cell function on glucose
disposal t0–210 remained present in the South Asians, but
disappeared in the Caucasian families, explaining the var-
iance of glucose disposal t0–210 in our final model by 22.7
and 8.9 % in South Asian and Caucasian families,
respectively (Table 2, Model 1). We also explored the
effect of ISR t0–30 and ISI on ISR t60–210. The unad-
justed relationships between ISI, ISR t0–30 and ISR
t60–210 are shown in the ternary plots of Supplementary
Figure 1b, d. After adjustment for age, W/H,WHO OGTT
subgroup and gender, ISR t0–30 in South Asians had an
effect on ISR t60–210, but such effects were not observed
in Caucasian families, explaining 45.5 and 17.4 % of the
variance of ISR t60–210 in our final model in South Asian
and Caucasian families, respectively (Table 2, Model 2).
We combined both ethnicities into an overall group and
applied both Model 1 and 2 and tested for interaction
between ethnicity and ISR t0–30 to glucose disposal
t0–210 or ISR t60–210, respectively; only in Model 2, this
interaction was significant (b = 0.341, [0.018;0.664]).
The overall DIs after logarithmic transformation of the
three WHO OGTT subgroups according to ethnicity are
shown in Fig. 1a. In both ethnicities, the overall DI
decreased from the NGT to the IFG/IGT and further to the
a
b
Fig. 1 a Overall DI (DI t0–210) for all WHO OGTT subgroups
(mean ± SEM) of both South Asian (closed) and Caucasian (open)
families (triangle represents NGT, square IFG/IGT and circle T2D
for both ethnicities). P values between subgroups in post hoc
Bonferroni analysis denoting statistical significance (P \ 0.0125) are
shown with symbols; *versus Cau NGT, versus Cau IFG/IGT,
versus Cau T2D, §versus SA NGT, ||versus SA IFG/IGT, }versus SA
T2D. b Early DI (DI t0–30) and late DI (t60–210) on left Y axis in
mean ± SEM, and ratio of late phase/early phase DI (right Y axis,
mean ± SEM) for NGT, IFG/IGT and T2D of both South Asian
(closed) and Caucasian (open) families (triangle represents NGT,
square IFG/IGT and circle T2D for both ethnicities). South Asians: In
early DI, there was a significant difference between NGT versus T2D
and IFG/IGT versus T2D (P \ 0.0001). In late DI, there was a
significant difference between NGT versus IFG/IGT, NGT versus
T2D and IFG/IGT versus T2D (P \ 0.0001). In DI ratio, no
significant differences were found (P = 0.14). Caucasians: In both
early and late DI, there was a significant difference between NGT
versus T2D and IFG/IGT versus T2D (both P \ 0.0001, respec-
tively). In DI ratio, there was a significant difference between NGT
versus T2D (P = 0.016)
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T2D groups. Illustrated in Fig. 1b, the early and late DIs of
the South Asian WHO OGTT subgroups were higher than
those of the equivalent Caucasian WHO OGTT subgroups,
although a more rapid decline could be observed between
South Asian NGT toward the IFG/IGT subgroup. In both
ethnicities, early as well as late DI of both NGT and IFG/IGT
subgroups differed significantly from their T2D subgroup.
We examined the ratio of early and late phase DI in the WHO
OGTT subgroups (Fig. 1b). In both the South Asian and the
Caucasian families, the IFG/IGTgroup had lower ratios
compared with the NGT group. This ratio was substantially
higher in the South Asians with T2D compared with their
relatives with IFG/IGT, whereas in the Caucasian families, a
very low late phase DI resulted in the lowest ratio.
Adjusted for age, W/H, WHO OGTT subgroup and
gender, DI ratio had an effect on glucose disposal t0–210 in
both ethnicities, with the explained variances of glucose
disposal t0–210 in our final model of 19.2 and 27.1 % in
South Asian and Caucasian families, respectively (Table 2,
Model 3). However, gender also played a role in Caucasian
families, but not in South Asian families.
Finally, to explore the differences in glucose handling in
the WHO OGTT subgroups within the ethnicities, ternaries
based on early DI are shown in Fig. 2a–b. (for total overview,
three ternaries based on overall, early and late DI are shown
in online Supplementary Fig. 2a–f). We used ordinal
regression analyses to examine the nature of the components
forming early and late DI. The ordinal analyses based on
Fig. 2 a, b Ternary plot of relationship between insulin sensitivity
(ISI), early phase beta-cell function (ISR t0–30) and glucose disposal
(incr. glucose AUC t0–30) based on OGTT from South Asian (figures
left) and Caucasian families (triangle represents NGT, square IFG/
IGT and circle T2D for both ethnicities)
Table 3 Ordinal and binary
logistic regression analysis in
both ethnicities predicting
WHO OGTT subgroups
adjusted for family ties
Bold values indicate the
significance of P values
Independent B SE Wald 95 % CI P value
Ordinal regression analysis with NGT, IFG/IGT and T2D as dependent variables
SA
ISR t0–30 -0.020 0.009 5.246 [-0.037; -0.002] 0.022
ISI -0.782 0.582 1.806 [-1.922; 0.359] 0.179
Cau
ISR t0–30 -0.066 0.020 11.128 [-0.105; -0.027] 0.001
ISI -0.603 0.256 5.556 [-1.105; -0.101] 0.018
Binary logistic regression analysis with T2D/non T2D as dependent variable
SA
ISR t0–30 -0.029 0.009 11.350 [-0.047; -0.011] 0.001
ISI -0.338 0.275 1.516 [-0.877; 0.201] 0.218
Cau
ISR t0–30 -0.017 0.006 7.859 [-0.029; -0.005] 0.005
ISI -0.319 0.124 6.630 [-0.562; -0.076] 0.01
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early DI parameters to predict WHO OGTT subgroups,
adjusted for family ties, are given in Table 3. In contrast to
Caucasians, there was an exclusive role for early beta-cell
function, and not ISI, in predicting glucose tolerance in the
South Asian families. Even when including early glucose
disposal (glucose disposal t0–30) as an additional covariate
in the analysis, ISR t0–30 remained the single significant
predictor. In the Caucasian families, both ISR t0–30 and ISI
contributed significantly. For both ethnicities, similar ordi-
nal analyses based on late DI parameters did not show sig-
nificant effects with the exception of late glucose disposal
t60–210 (data not shown). Figure 2a–b suggest that the
groups with T2D occupy a more distinct area toward the left
corner of the ternaries, whereas the other two groups overlap
more in the center. Therefore, we also performed logistic
regression, adjusted for family ties, with the T2D groups
versus the other relatives, the results can be found in Table 3;
again, ISR t0–30 remained the most important discriminat-
ing variable in South Asians, even when glucose disposal
t0–30 was included. For both ethnicities, similar binary
logistic regression analyses based on late DI parameters
demonstrated glucose disposal t60–210 as the most dis-
criminating variable (data not shown).
Discussion
Across WHO OGTT subgroups from South Asian families,
including the NGT group, we observed more insulin resis-
tance, with more rapid decline of both early and late DI in
NGT toward IFG/IGT, suggestive of early onset beta-cell
failure. Across the WHO OGTT subgroups in Caucasian
families, we observed a clear trend from normal insulin
sensitivity to insulin resistance, while the DI decreased.
Among the South Asians, the early insulin response
explained at least partly the late insulin response as well as
the overall glucose disposal. The ratio of the late over early
DI decreased in both ethnicities from NTG to IFG/IGT, but
waxed in the South Asian T2D and waned in the Caucasian
T2D group, resulting in significant, but opposing effects in
both ethnicities on the overall glucose disposal. The South
Asians developed overt T2D at young age, while they still
had a relatively high DI ratios. As a result of the lack of
variance between the South Asian WHO OGTT subgroups in
insulin sensitivity, only the early ISR predicted glucose
tolerance state. Taken together, our findings confirm that
changes in beta-cell dynamics play a prominent role in the
development of T2D in South Asians. In Caucasians, more
gradual processes of increasing resistance to insulin and
decreasing overall insulin secretion seem to take place.
Our data confirm that—without adjustment for insulin
sensitivity—South Asian individuals wrongly seem to have
enough beta-cell capacity (Supplementary Table 1) with an
above-average ability to secrete insulin [15]. Unfortu-
nately, this compensatory beta-cell function is insufficient,
leading to very early onset of T2D, as shown by the young
age of manifest T2D in South Asians. These observations
underline the important role of changes in beta-cell func-
tion, which have been reported to be the main contributor
to abnormal glucose tolerance among a wide range of
ethnicities, and are in line with increasing genetic evidence
for beta-cell defects as an important predisposing factor for
T2D [16, 17]. Hypersecretion of insulin may reflect beta-
cell responses to different signals or a combination of an
increased potentiating effect of glucose on beta-cells, long-
lasting adaptation to severe insulin resistance and/or
problems with the processing of insulin.
Clamp studies have demonstrated decreased insulin
sensitivity among healthy South Asians when compared to
other healthy controls [26–29]. We also found a decreased
insulin sensitivity in the South Asians compared with the
Caucasians. In contrast to the Caucasians, the degree of
insulin sensitivity did not change between the three South
Asian WHO OGTT subgroups. This very strong familial
aggregation of insulin resistance suggests a strong contri-
bution of environmental factors. However, we cannot infer
from our data whether lifestyle, type of food, microbiome
or other factors are involved. Among our families with high
risk of T2D, the South Asians had much earlier onset of
signs and symptoms of T2D compared with Caucasians.
Notably, the burden from macrovascular disease was larger
in our South Asian families, even in relatives who did not
have T2D. This suggests that the severe insulin resistance
of the South Asians contributes strongly to atherogenesis.
In addition to a demanding insulin resistant environment,
failing beta-cell capacity is a major susceptibility factor to
T2D in South Asian families, as was supported by recent
genome wide association studies (GWAS). These studies
show greater effects of SNP variants in beta-cell-related
genes in South Asians than in other populations [30].
The strength of the present study is that it was a family-
based approach and analysis of two ethnic groups, among
various stages of glucose tolerance. Moreover, beta-cell and
insulin sensitivity indices were based on multiple sampled
prolonged OGTT’s. The relatively small numbers within the
WHO OGTT subgroups of the families are a potential
weakness, but a characteristic of both extensive phenotyping
and family analyses is that it can be performed in relatively
small populations. In line, we were able to observe beta-cell
function alterations in a very consistent way.
Conclusion
Based on extended OGTT measurements, we found that
insulin sensitivity is already lower in South Asian than in
18 Acta Diabetol (2015) 52:11–19
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Caucasian people with NGT. Insulin resistance in the South
Asians does not change much during progression of glu-
cose intolerance, and beta-cell dysfunction might play a
dominant role in the early development of T2D among
South Asian families in the Netherlands.
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